# Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Study · id `cardio:ct-nct06587737` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06587737](<https://clinicaltrials.gov/study/NCT06587737>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06587737

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1125 participants.

## Technical summary

Registry record NCT06587737. Randomized; quadruple masking; primary purpose prevention. Start 2026-09-30 (anticipated); primary completion 2028-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1125 participants (planned count; ClinicalTrials.gov record NCT06587737, source copy `cardio:ctgov-nct06587737-2026-09-01`, retrieved 2026-10-26)
- Planned start: 2026-09-30 (anticipated) (ClinicalTrials.gov record NCT06587737, source copy `cardio:ctgov-nct06587737-2026-09-01`, retrieved 2026-10-26)
- Primary completion: 2028-07-30 (anticipated) (ClinicalTrials.gov record NCT06587737, source copy `cardio:ctgov-nct06587737-2026-09-01`, retrieved 2026-10-26)
- Completion: 2028-10-30 (anticipated) (ClinicalTrials.gov record NCT06587737, source copy `cardio:ctgov-nct06587737-2026-09-01`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06587737-2026-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage
- Acronym: CoVasc-ICH2
- Condition: Colchicine
- Condition: ICH - Intracerebral Hemorrhage
- Condition: Stroke
- Condition: Dependence
- Intervention (Drug): Colchicine 0.5 MG
- Intervention (Drug): Placebo
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: e8910b610e2badee21555fbda15a400e92ee12b6515e051598d636b4445122b6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
